Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Keryx Biopharmaceuticals Inc. (KERX)

15.05 0.30(1.95%) Jul 31, 3:59PM EDT
|Pre-Market : 15.07 Up 0.01 (0.07%) 8:46AM EDT - Nasdaq Real Time Price
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:1.38B
Enterprise Value (Aug 1, 2014)3:1.22B
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2015)1:75.25
PEG Ratio (5 yr expected)1:-0.64
Price/Sales (ttm):140.38
Price/Book (mrq):9.73
Enterprise Value/Revenue (ttm)3:122.14
Enterprise Value/EBITDA (ttm)6:-22.01
Financial Highlights 
Fiscal Year
Fiscal Year Ends:Dec 31
Most Recent Quarter (mrq):Mar 31, 2014
Profit Margin (ttm):N/A
Operating Margin (ttm):-555.76%
Management Effectiveness
Return on Assets (ttm):-27.47%
Return on Equity (ttm):-51.11%
Income Statement
Revenue (ttm):10.00M
Revenue Per Share (ttm):0.12
Qtrly Revenue Growth (yoy):42.90%
Gross Profit (ttm):7.00M
EBITDA (ttm)6:-55.50M
Net Income Avl to Common (ttm):-58.21M
Diluted EPS (ttm):-0.70
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):154.92M
Total Cash Per Share (mrq):1.69
Total Debt (mrq):0.00
Total Debt/Equity (mrq):N/A
Current Ratio (mrq):9.55
Book Value Per Share (mrq):1.58
Cash Flow Statement
Operating Cash Flow (ttm):-42.23M
Levered Free Cash Flow (ttm):-19.24M
View Financials
Income Statement - Balance Sheet - Cash Flow

Trading Information 
Stock Price History
52-Week Change3:63.23%
S&P500 52-Week Change3:12.93%
52-Week High (Mar 31, 2014)3:17.46
52-Week Low (Aug 19, 2013)3:8.29
50-Day Moving Average3:14.91
200-Day Moving Average3:14.77
Share Statistics
Avg Vol (3 month)3:1,616,400
Avg Vol (10 day)3:1,246,010
Shares Outstanding5:91.45M
% Held by Insiders1:2.11%
% Held by Institutions1:66.60%
Shares Short (as of May 30, 2014)3:19.70M
Short Ratio (as of May 30, 2014)3:10.50
Short % of Float (as of May 30, 2014)3:22.00%
Shares Short (prior month)3:20.27M
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:N/A
Last Split Date3:N/A

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Mar 31, 2014)
ttm = Trailing Twelve Months (as of Mar 31, 2014)
yoy = Year Over Year (as of Mar 31, 2014)
lfy = Last Fiscal Year (as of Dec 31, 2013)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in USD.